Strides Pharma Science shares zoom 12% after its arm receives USFDA approval for Dolutegravir tablets
Strides Pharma Science share price NSE: Pharmaceutical company Strides Pharma Science shares rallied on Friday for the third straight day and zoomed nearly 12 per cent to clock a fresh 52-week high of Rs 522.75
![Strides Pharma Science shares zoom 12% after its arm receives USFDA approval for Dolutegravir tablets](https://cdn.zeebiz.com/sites/default/files/2023/09/15/260802-strides-pharma-share-price-target-2023.jpg?im=FitAndFill=(1200,900))
Strides Pharma Science share price: Pharmaceutical company Strides Pharma Science shares rallied on Friday for the third straight day and zoomed nearly 12 per cent to clock a fresh 52-week high of Rs 522.75, surpassing the previous 52-week high of Rs 490.05, clocked on September 8, 2023. The stock jumped after its wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received tentative approval for Dolutegravir 50mg tablets from the United States Food & Drug Administration (USFDA). Strides Pharma Science shares closed 5.29 per cent or Rs 24.75 higher at 492.9 on NSE.
The product is bioequivalent and therapeutically equivalent to the reference-listed drug (RLD), Tivicay Tablets, of ViiV Healthcare Company. The products will be manufactured at the company’s facility in Bengaluru, and conversion of this tentative approval to a full approval is expected upon expiry of the constraining patents. The company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of which 230+ ANDAs have been approved. The company is eyeing around 60 new product launches over the next three years in the US.
Here's how the counter moved on Friday, Sepetmber 15:
Source: NSE
What are Dolutegravir 50mg tablets?
Belonging to a class of medication, Dolutegravir tablets are known as antiretrovirals. The medication is the first line of antiretroval therapy (ART) for treatment-naïve patients. It works by preventing the multiplication of the virus in human cells.
What does Strides do?
Strides is a global pharmaceutical company headquartered in Bengaluru. The company mainly operates in regulated markets and has an "in Africa for Africa" strategy and an institutional business to service donor-funded markets.
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
![https://www.zeebiz.com/markets/stocks/photo-gallery-this-tata-group-stock-turned-every-rs-10000-of-investment-into-rs-11300-in-just-a-week-investors-richer-by-42722-crore-rupees-any-guesses-share-market-news-304023](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/26/307143-tradingpexels.jpg?itok=rw4R7EfH)
A Tata group stock just turned every Rs 10,000 of investment into Rs 11,300 in just a week, investors richer by Rs 42,722 crore; any guesses?
![https://www.zeebiz.com/markets/stocks/photo-gallery-large-cap-midcap-stocks-shares-to-buy-for-long-term-check-out-targets-nifty-sensex-303617](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/25/306716-stockks.jpg?itok=KJTrFUIK)
Stocks to buy for long term: Analysts suggest buying these 5 largecap, 4 midcap scrips; check out targets
![https://www.zeebiz.com/personal-finance/photo-gallery-nps-retirement-planning-budget-2024-nirmala-sitharaman-announcement-how-nps-rulebook-change-can-increase-corpus-income-and-monthly-pension-by-40-compound-return-303984](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/26/307102-indian-currency-pixabay-take.jpg?itok=kN21EW-9)
How your NPS retirement corpus and monthly pension can jump by 40% after this rule change; get details
![https://www.zeebiz.com/personal-finance/photo-gallery-senior-citizen-savings-scheme-scss-2024-interest-rate-calculator-post-office-how-to-get-inr-rs-50000-interest-retirement-planning-guaranteed-return-maturity-amount-small-savings-303930](https://cdn.zeebiz.com/sites/default/files/styles/zeebiz_700x394/public/2024/07/26/307042-fd-interest-file.jpg?itok=45ZbBRWM)
How much investment do you need in this senior citizen scheme to get Rs 50,000 quarterly interest? Know here
03:51 PM IST